Search papers, labs, and topics across Lattice.
DeepMind
Google ResearchBabylon HealthBeth Israel Deaconess Medical CenterBeth Israel Lahey HealthEqual leadershipHarvardMassachusetts General HospitalNankai UniversityNKIARIMar 9, 2026arXiv:2603.08448This study prospectively evaluated the feasibility of the LLM-based conversational AI, AMIE, for clinical history taking and differential diagnosis in an ambulatory primary care setting with 100 patients. AMIE demonstrated high patient satisfaction, improved patient attitudes towards AI, and was deemed useful by PCPs, with human safety supervisors not needing to intervene during consultations. AMIE's differential diagnosis included the final diagnosis in 90% of cases, achieving comparable overall quality to PCPs, although PCPs outperformed AMIE in practicality and cost-effectiveness of management plans.
LLM-powered diagnostic AI is ready for prime time: a real-world clinical trial shows it's safe, patients love it, and doctors find it useful.
Large language model (LLM)-based AI systems have shown promise for patient-facing diagnostic and management conversations in simulated settings. Translating these systems into clinical practice requires assessment in real-world workflows with rigorous safety oversight. We report a prospective, single-arm feasibility study of an LLM-based conversational AI, the Articulate Medical Intelligence Explorer (AMIE), conducting clinical history taking and presentation of potential diagnoses for patients to discuss with their provider at urgent care appointments at a leading academic medical center. 100 adult patients completed an AMIE text-chat interaction up to 5 days before their appointment. We sought to assess the conversational safety and quality, patient and clinician experience, and clinical reasoning capabilities compared to primary care providers (PCPs). Human safety supervisors monitored all patient-AMIE interactions in real time and did not need to intervene to stop any consultations based on pre-defined criteria. Patients reported high satisfaction and their attitudes towards AI improved after interacting with AMIE (p<0.001). PCPs found AMIE's output useful with a positive impact on preparedness. AMIE's differential diagnosis (DDx) included the final diagnosis, per chart review 8 weeks post-encounter, in 90% of cases, with 75% top-3 accuracy. Blinded assessment of AMIE and PCP DDx and management (Mx) plans suggested similar overall DDx and Mx plan quality, without significant differences for DDx (p = 0.6) and appropriateness and safety of Mx (p = 0.1 and 1.0, respectively). PCPs outperformed AMIE in the practicality (p = 0.003) and cost effectiveness (p = 0.004) of Mx. While further research is needed, this study demonstrates the initial feasibility, safety, and user acceptance of conversational AI in a real-world setting, representing crucial steps towards clinical translation.
